MEE (drug)

MEE
Clinical data
Other names2-Methoxy-4,5-diethoxyphenethylamine; TMA2-4,5-DiEtO
Routes of
administration
Oral[1]
ATC code
  • None
Pharmacokinetic data
Duration of actionUnknown[1]
Identifiers
  • 1-(4,5-diethoxy-2-methoxyphenyl)propan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC14H23NO3
Molar mass253.342 g·mol−1
3D model (JSmol)
  • CCOc1cc(OC)c(cc1OCC)CC(C)N
  • InChI=1S/C14H23NO3/c1-5-17-13-8-11(7-10(3)15)12(16-4)9-14(13)18-6-2/h8-10H,5-7,15H2,1-4H3 checkY
  • Key:LKJRFMXILZHUHU-UHFFFAOYSA-N checkY
  (verify)

MEE, also known as 2-methoxy-4,5-diethoxyamphetamine or as TMA2-4,5-DiEtO, is a chemical compound of the phenethylamine, amphetamine, and DOx families related to the psychedelic drug TMA-2.[1][2][3] It is a diethoxy-methoxy analogue of TMA-2.[1] MEE was first synthesized by Alexander Shulgin.[1] In his book PiHKAL, both the dosage and duration are unknown.[1] MEE produces few to no effects.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of MEE.[1]

See also

References

  1. ^ a b c d e f g h Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628. MEE entry
  2. ^ Shulgin AT (2003). "Basic Pharmacology and Effects". In Laing RR (ed.). Hallucinogens: A Forensic Drug Handbook. Forensic Drug Handbook Series. Elsevier Science. pp. 67–137. ISBN 978-0-12-433951-4. Archived from the original on 13 July 2025.
  3. ^ Shulgin AT (January 1968). "The ethyl homologs of 2,4,5-trimethoxyphenylisopropylamine". J Med Chem. 11 (1): 186–187. doi:10.1021/jm00307a056. PMID 5637180. Archived from the original on 2025-07-12.